Search research articles
Contact Us
Filters
Showing results (11-20 of 76) with videos related to
Page
of 8
Sort By:
Attention Deficit and Hyperactivity Disorders
|
March 25, 2011
Minor differences in ADHD-related difficulties between boys and girls treated with atomoxetine for attention-deficit/hyperactivity disorder
Peter M Wehmeier, Alexander Schacht, Ralf W Dittmann, et al.
Frontiers in Psychiatry
|
December 8, 2018
Screening for ADHD-Related Symptoms in Preschoolers Should Be Considered-Results From a Representative Sample of 5-Year-Olds From a German Metropolitan Region
Konstantin Mechler, Thomas Krömer, Michael Landauer, et al.
Attention Deficit and Hyperactivity Disorders
|
March 18, 2010
Self-esteem in adolescent patients with attention-deficit/hyperactivity disorder during open-label atomoxetine treatment: psychometric evaluation of the Rosenberg Self-Esteem Scale and clinical findings
Ralf W Dittmann, Peter M Wehmeier, Alexander Schacht, et al.
Journal of Attention Disorders
|
August 30, 2012
Does Comorbid Disruptive Behavior Modify the Effects of Atomoxetine on ADHD Symptoms as Measured by a Continuous Performance Test and a Motion Tracking Device?
Peter M Wehmeier, Laura Kipp, Tobias Banaschewski, et al.
European Child & Adolescent Psychiatry
|
August 24, 2004
Non-stimulant medications in the treatment of ADHD
Tobias Banaschewski, Veit Roessner, Ralf W Dittmann, et al.
Child and Adolescent Psychiatry and Mental Health
|
February 11, 2009
Morning and evening behavior in children and adolescents treated with atomoxetine once daily for attention-deficit/hyperactivity disorder (ADHD): findings from two 24-week, open-label studies
Peter M Wehmeier, Ralf W Dittmann, Alexander Schacht, et al.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie
|
December 8, 2016
Non-adherence to Psychotropic Medication Among Adolescents - A Systematic Review of the Literature
Alexander Häge, Lisa Weymann, Lucia Bliznak, et al.
Journal of Child and Adolescent Psychopharmacology
|
August 28, 2018
"When I Stop My Medication, Everything Goes Wrong": Content Analysis of Interviews with Adolescent Patients Treated with Psychotropic Medication
Larissa Niemeyer, Lucca Schumm, Konstantin Mechler, et al.
Contemporary Clinical Trials Communications
|
September 12, 2022
Memantine as treatment for compulsivity in child and adolescent psychiatry: Descriptive findings from an incompleted randomized, double-blind, placebo-controlled trial
Larissa Niemeyer, Konstantin Mechler, Ralf W Dittmann, et al.
Journal of Child and Adolescent Psychopharmacology
|
November 2, 2011
Neuropsychological outcomes across the day in children with attention-deficit/hyperactivity disorder treated with atomoxetine: results from a placebo-controlled study using a computer-based continuous performance test combined with an infra-red motion-tracking device
Peter M Wehmeier, Alexander Schacht, Christian Wolff, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 76) with videos related to
Sort By:
Page
of 8
Attention Deficit and Hyperactivity Disorders
|
March 25, 2011
Minor differences in ADHD-related difficulties between boys and girls treated with atomoxetine for attention-deficit/hyperactivity disorder
Peter M Wehmeier, Alexander Schacht, Ralf W Dittmann, et al.
Frontiers in Psychiatry
|
December 8, 2018
Screening for ADHD-Related Symptoms in Preschoolers Should Be Considered-Results From a Representative Sample of 5-Year-Olds From a German Metropolitan Region
Konstantin Mechler, Thomas Krömer, Michael Landauer, et al.
Attention Deficit and Hyperactivity Disorders
|
March 18, 2010
Self-esteem in adolescent patients with attention-deficit/hyperactivity disorder during open-label atomoxetine treatment: psychometric evaluation of the Rosenberg Self-Esteem Scale and clinical findings
Ralf W Dittmann, Peter M Wehmeier, Alexander Schacht, et al.
Journal of Attention Disorders
|
August 30, 2012
Does Comorbid Disruptive Behavior Modify the Effects of Atomoxetine on ADHD Symptoms as Measured by a Continuous Performance Test and a Motion Tracking Device?
Peter M Wehmeier, Laura Kipp, Tobias Banaschewski, et al.
European Child & Adolescent Psychiatry
|
August 24, 2004
Non-stimulant medications in the treatment of ADHD
Tobias Banaschewski, Veit Roessner, Ralf W Dittmann, et al.
Child and Adolescent Psychiatry and Mental Health
|
February 11, 2009
Morning and evening behavior in children and adolescents treated with atomoxetine once daily for attention-deficit/hyperactivity disorder (ADHD): findings from two 24-week, open-label studies
Peter M Wehmeier, Ralf W Dittmann, Alexander Schacht, et al.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie
|
December 8, 2016
Non-adherence to Psychotropic Medication Among Adolescents - A Systematic Review of the Literature
Alexander Häge, Lisa Weymann, Lucia Bliznak, et al.
Journal of Child and Adolescent Psychopharmacology
|
August 28, 2018
"When I Stop My Medication, Everything Goes Wrong": Content Analysis of Interviews with Adolescent Patients Treated with Psychotropic Medication
Larissa Niemeyer, Lucca Schumm, Konstantin Mechler, et al.
Contemporary Clinical Trials Communications
|
September 12, 2022
Memantine as treatment for compulsivity in child and adolescent psychiatry: Descriptive findings from an incompleted randomized, double-blind, placebo-controlled trial
Larissa Niemeyer, Konstantin Mechler, Ralf W Dittmann, et al.
Journal of Child and Adolescent Psychopharmacology
|
November 2, 2011
Neuropsychological outcomes across the day in children with attention-deficit/hyperactivity disorder treated with atomoxetine: results from a placebo-controlled study using a computer-based continuous performance test combined with an infra-red motion-tracking device
Peter M Wehmeier, Alexander Schacht, Christian Wolff, et al.
Page
of 8